Publication | Open Access

Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX

Molecular PharmacologyMedicinal ChemistryPharmaceutical SciencePharmaceutical ChemistryBiochemistryMedicineNatural SciencesNovel Sulfanilamide/acetazolamide DerivativesAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyTail ApproachInhibitory ActivityDrug DiscoveryCarbonic Anhydrase Inhibitors